41 Results for "

C5aR

" in MedChemExpress (MCE) Product Catalog:
Products (41)

41 Results for "C5aR" in MCE Product Catalog:

14
14 Publications Verification
Cat. No.: HY-110136
CAS No.: 514814-49-4
Purity:  99.54%
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

PMX 205 is a potent complement C5a receptor (C5aR; CD88) antagonist.
loading...
    loading...
14
14 Publications Verification
Cat. No.: HY-110136A
Purity:  99.50%
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

PMX 205 Trifluoroacetate is a specific complement C5aR1 isoform antagonist .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-106178
CAS No.: 219639-75-5
Purity:  99.98%
Synonyms: 3D53
PMX-53 (3D53) is a synthetic peptidic and a potent and orally active complement C5a receptor (CD88) antagonist with an IC50 of 20 nM. PMX-53 is also a low-affinity MrgX2 agonist that stimulates MrgX2-mediated mast cell degranulation. PMX-53 specifically binds to C5aR1 and does not bind to the second C5aR (C5L2) and C3aR. PMX-53 has anti-inflammatory, anticancer and antiatherosclerotic effects [5] .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-17627
CAS No.: 1346623-17-3
Synonyms: CCX168
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

Avacopan (CCX168) is a potent, selective and orally available complement 5a receptor (C5aR) inhibitor with an IC50 of 0.1 nM.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-148141
CAS No.: 1254036-23-1
Purity:  99.96%
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

JPE-1375 is a complement C5a receptor 1 (C5aR1) antagonist. JPE-1375 effectively inhibits polymorphonuclear leukocyte mobilization (EC50=6.9 μM) and reduces TNF levels (EC50=4.5 μM) in mice. JPE-1375 can be used in studies of autoimmune and inflammatory diseases .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-145237
CAS No.: 2891606-02-1
Purity:  99.81%
BM213 is a selective C5aR agonist, with an EC50 of 59 nM. BM213 specifically activates the C5a-C5aR1 axis, which in turn promotes neutrophil extracellular trap (NET) formation and exacerbates inflammatory responses. BM213 significantly induces ventricular dilationin, promotes myocardial ROS production, and induces cardiomyocyte apoptosis in rats. BM213 can be used for the study of myocardial ischemia/reperfusion (I/R) injury .
loading...
    loading...
Cat. No.: HY-P99450
CAS No.: 2226393-85-5
Synonyms: IPH 5401; Anti-C5aR1 mAb

Target:  

Complement System

Research Areas:  

Inflammation/Immunology Cancer

Avdoralimab (IPH 5401) is a fully human IgGκ monoclonal antibody that targets the complement C5a receptor 1 (C5aR1) that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research .
loading...
    loading...
Cat. No.: HY-110060
CAS No.: 439571-48-9
Purity:  99.35%
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

NDT 9513727 is a potent, selective, orally active and competitive inverse agonist of the human C5aR (C5a receptor), with an IC50 of 11.6 nM. NDT 9513727 can be used for the research of human inflammatory diseases .
loading...
    loading...
Cat. No.: HY-P5506
CAS No.: 144555-23-7
Target:  

Complement System

Research Areas:  

Others

C5a Receptor agonist, W5Cha (Peptide 1) is a selective complement C5a receptor (C5aR) agonist (EC50=0.2 μM), a hexapeptide derived from the C-terminus of C5a with specific amino acid modifications. C5a Receptor agonist, W5Cha is able to interact with the Arg-206 site of the C5a receptor through its C-terminal arginine, thereby activating the receptor .
loading...
    loading...
Cat. No.: HY-117971
CAS No.: 1374984-75-4
Purity:  99.97%
Research Areas:  

Others

BVT173187 is a selective inhibitor of the neutrophil formyl peptide receptor FPR1, with activity that inhibits FPR1 activation. BVT173187 inhibits FPR1 agonist-induced activation in neutrophils, reduces adhesion molecule mobilization and superoxide anion production, and has inhibitory activity on FPR1 similar to that of earlier described peptide antagonists, but also has effects on C5aR and CXCR signaling.
loading...
    loading...
Cat. No.: HY-P10639
CAS No.: 2097449-46-0
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

C5aR2 agonist P32 (Ac-RHYPYWR-OH) is a C5aR2-selective agonist. C5aR2 agonist P32 has been shown to elicit multiple immunomodulatory activities, both by down-regulating the C5aR1-mediated cell signalling, and acting in a C5aR1-independent fashion, in vitro and in vivo .
loading...
    loading...
Cat. No.: HY-183414
CAS No.: 1257868-45-3
Target:  

Complement System

Research Areas:  

Endocrinology

C5aR antagonist-1 is a potent C5aR antagonist with an IC50 of < 5 nM. C5aR antagonist-1 is applicable to the research of crescentic and necrotizing glomerular lesions .
loading...
    loading...
Cat. No.: HY-P991796

Target:  

Complement System

Research Areas:  

Others

Anti-Mouse C5aR Antibody (20/70) reacts with mouse C5aR. Anti-Mouse C5aR Antibody (20/70) blocks C5aR both in vivo and in vitro. Recommend Isotype Controls: Rat IgG2b kappa, Isotype Control (HY-P990682) .
loading...
    loading...
Cat. No.: HY-P990745
CAS No.: 2769937-42-8
Synonyms: HIB210; MOR044254; MOR210; TJ-210; TJ-210001; WBP2191

Target:  

Complement System

Research Areas:  

Inflammation/Immunology

Izastobart is an anti-C5AR1 human IgG1 λ2 monoclonal antibody . Recommend Isotype Controls: Human IgG1 lambda2, Isotype Control (HY-P990096).
loading...
    loading...
Cat. No.: HY-147585
CAS No.: 2761048-02-4
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

C5aR-IN-1 is a potent inhibitor of C5aR. Increased level of C5a has been associated with disorders such as autoimmune disorders and inflammatory disorders. C5aR-IN-1 has the potential for the research of inflammation diseases (extracted from patent WO2022028586A1, compound 47) .
loading...
    loading...
Cat. No.: HY-147586
CAS No.: 2761048-06-8
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

C5aR-IN-2 is a potent inhibitor of C5aR. Increased level of C5a has been associated with disorders such as autoimmune disorders and inflammatory disorders. C5aR-IN-2 has the potential for the research of inflammation diseases (extracted from patent WO2022028586A1, compound 49) .
loading...
    loading...
Cat. No.: HY-147587
CAS No.: 2761048-50-2
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

C5aR-IN-3 is a potent inhibitor of C5aR. Increased level of C5a has been associated with disorders such as autoimmune disorders and inflammatory disorders. C5aR-IN-3 has the potential for the research of inflammation diseases (extracted from patent WO2022028586A1, compound 89) .
loading...
    loading...
Cat. No.: HY-17627R
CAS No.: 1346623-17-3
Synonyms: CCX168 (Standard)
Avacopan (Standard) is the analytical standard of Avacopan. This product is intended for research and analytical applications. Avacopan (CCX168) is a potent, selective and orally available complement 5a receptor (C5aR) inhibitor with an IC50 of 0.1 nM.
loading...
    loading...
Cat. No.: HY-P991485

Target:  

Complement System

Research Areas:  

Inflammation/Immunology

Anti-CD88/C5AR1 Antibody (G2_anti-C5aR) is a human monoclonal antibody (mAb) targeting C5AR1.
loading...
    loading...
Cat. No.: HY-163378
CAS No.: 2365325-67-1
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

C5aR1 antagonist 1 (Compound 7e) is an orally active C5a receptor 1 (C5aR1) antagonist. C5aR1 antagonist 1 is active in DISCO and migration assays, with IC50 values of 38 nM and 17 nM, respectively. C5aR1 antagonist 1 can be used for the research of acute and chronic inflammatory diseases .
loading...
    loading...